Matinas BioPharma (MTNB) Short Interest Ratio & Short Volume → Invest in the 'Trojan Horse' of Alzheimer's Treatment (From Behind the Markets) (Ad) Free MTNB Stock Alerts $0.17 0.00 (0.00%) (As of 05/16/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartEarningsHeadlinesOwnershipShort InterestStock AnalysisAnalyst ForecastsChartEarningsHeadlinesOwnershipShort Interest Matinas BioPharma Short Interest DataCurrent Short Volume3,240,000 sharesPrevious Short Volume3,190,000 sharesChange Vs. Previous Month+1.57%Dollar Volume Sold Short$0.00Short Interest Ratio / Days to Cover2.0Last Record DateApril 30, 2024Outstanding Shares250,820,000 sharesPercentage of Shares Shorted1.29%Today's Trading Volume1,894,639 sharesAverage Trading Volume1,375,425 sharesToday's Volume Vs. Average138% Short Selling Matinas BioPharma ? Sign up to receive the latest short interest report for Matinas BioPharma and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatMTNB Short Interest Over TimeMTNB Days to Cover Over TimeMTNB Percentage of Float Shorted Over Time Ad Weiss RatingsThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-up before it’s too late. It’s urgent because it’s what we consider “The #1 Crypto for the AI World.”Learn more about it by watching THIS NOW. Matinas BioPharma Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20243,240,000 shares $0.00 +1.6%N/A2 $0.00 4/15/20243,190,000 shares $0.00 -2.5%N/A2.1 $0.00 3/31/20243,270,000 shares $0.00 +147.7%N/A2.2 $0.00 3/15/20241,320,000 shares $0.00 -10.2%N/A1 $0.00 2/29/20241,470,000 shares $0.00 +22.5%N/A1.5 $0.00 2/15/20241,200,000 shares $0.00 -15.5%N/A1.2 $0.00 Get the Latest News and Ratings for MTNB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Matinas BioPharma and its competitors with MarketBeat's FREE daily newsletter. 1/31/20241,420,000 shares $0.00 +8.4%N/A1 $0.00 1/15/20241,310,000 shares $0.00 -36.4%N/A0.8 $0.00 12/31/20232,060,000 shares $0.00 -10.0%N/A0.2 $0.00 12/15/20232,290,000 shares $0.00 -34.4%N/A0.2 $0.00 11/30/20233,490,000 shares $0.00 -21.6%N/A0.4 $0.00 11/15/20234,450,000 shares $0.00 -2.8%N/A0.5 $0.00 10/31/20234,580,000 shares $0.00 -23.9%N/A0.5 $0.00 10/15/20236,020,000 shares $0.00 +3,030.5%N/A0.7 $0.00 9/30/2023192,300 shares $0.00 -31.0%N/A0.2 $0.00 9/15/2023278,500 shares $0.00 -60.9%N/A0.4 $0.00 8/31/2023711,500 shares $0.00 -38.1%N/A1.1 $0.00 8/15/20231,150,000 shares $0.00 -24.8%N/A1.7 $0.00 7/31/20231,530,000 shares $0.00 +11.7%N/A3.2 $0.00 7/15/20231,370,000 shares $0.00 -14.4%N/A2.8 $0.00 6/30/20231,600,000 shares $576,000.00 +4.6%N/A2.9 $0.36 6/15/20231,530,000 shares $0.00 +25.4%N/A3 $0.00 5/31/20231,220,000 shares $0.00 -12.9%N/A2.5 $0.00 5/15/20231,400,000 shares $0.00 -14.1%N/A3.2 $0.00 4/30/20231,630,000 shares $0.00 +48.2%N/A4.4 $0.00 4/15/20231,100,000 shares $0.00 -9.8%N/A3 $0.00 3/31/20231,220,000 shares $0.00 +8.9%N/A4.4 $0.00 3/15/20231,120,000 shares $0.00 -26.8%N/A3.6 $0.00 2/28/20231,530,000 shares $0.00 +10.1%N/A3.9 $0.00 2/15/20231,390,000 shares $0.00 -6.1%N/A3.5 $0.00 1/31/20231,480,000 shares $0.00 +5.0%N/A3.8 $0.00 1/15/20231,410,000 shares $0.00 -2.1%N/A3.2 $0.00 12/30/20221,440,000 shares $720,000.00 -23.4%N/A3.4 $0.50 12/15/20221,880,000 shares $0.00 +20.5%N/A4.7 $0.00 11/30/20221,560,000 shares $0.00 -2.5%N/A4.7 $0.00 11/15/20221,600,000 shares $0.00 -3.0%N/A5.8 $0.00 10/31/20221,650,000 shares $1.29 million +2.5%N/A5.4 $0.78 10/15/20221,610,000 shares $0.00 -6.4%N/A5.1 $0.00 9/30/20221,720,000 shares $0.00 +1.2%N/A5.8 $0.00 9/15/20221,700,000 shares $0.00 +6.3%N/A5 $0.00Invest in the "Trojan Horse" of Alzheimer's Treatment (Ad)This one tiny Micro-Cap is at the forefront of what may be the most significant development in healthcare since the discovery of antibiotics.Click here and learn how you can invest in this incredible opportunity>>> MTNB Short Interest - Frequently Asked Questions What is Matinas BioPharma's current short interest? Short interest is the volume of Matinas BioPharma shares that have been sold short but have not yet been covered or closed out. As of April 30th, investors have sold 3,240,000 shares of MTNB short. Learn More on Matinas BioPharma's current short interest. What is a good short interest ratio for Matinas BioPharma? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. MTNB shares currently have a short interest ratio of 2.0. Learn More on Matinas BioPharma's short interest ratio. Is Matinas BioPharma's short interest increasing or decreasing? Matinas BioPharma saw a increase in short interest in the month of April. As of April 30th, there was short interest totaling 3,240,000 shares, an increase of 1.6% from the previous total of 3,190,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Matinas BioPharma's short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Matinas BioPharma: Ocuphire Pharma, Inc. (4.71%), HCW Biologics Inc. (0.05%), NextCure, Inc. (0.53%), Gain Therapeutics, Inc. (1.02%), Eyenovia, Inc. (12.11%), CASI Pharmaceuticals, Inc. (0.73%), VYNE Therapeutics Inc. (0.68%), Earth Science Tech, Inc. (0.00%), Unicycive Therapeutics, Inc. (2.13%), Aadi Bioscience, Inc. (6.50%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Matinas BioPharma stock? Short selling MTNB is an investing strategy that aims to generate trading profit from Matinas BioPharma as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Matinas BioPharma? A short squeeze for Matinas BioPharma occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of MTNB, which in turn drives the price of the stock up even further. How often is Matinas BioPharma's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MTNB, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: Ocuphire Pharma Short Interest HCW Biologics Short Interest NextCure Short Interest Gain Therapeutics Short Interest Eyenovia Short Interest CASI Pharmaceuticals Short Interest VYNE Therapeutics Short Interest Earth Science Tech Short Interest Unicycive Therapeutics Short Interest Aadi Bioscience Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NYSEAMERICAN:MTNB) was last updated on 5/17/2024 by MarketBeat.com Staff From Our PartnersInvest in the "Trojan Horse" of Alzheimer's TreatmentBehind the MarketsObama’s Forever Term [exposed]Porter & CompanyGold Set to EXPLODE!Gold Safe ExchangeThe 1,000X Crypto PlaybookTrue Market InsidersUrgent Nvidia WarningAltimetryCharles Payne Demystifies OptionsUnstoppable ProsperityBiden FINISHED On June 13th?Paradigm PressWhy Is Gold On a MASSIVE rally? Huge Alerts